Medical Ikkou Group Co.,Ltd.

TSE:3353.T

2103 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 39,900.98833,897.59833,595.9931,603.66732,042.45431,222.17530,914.96829,489.66929,305.78626,387.27322,873.54220,574.65919,576.61917,974.01317,184.76716,068.897
Cost of Revenue 35,520.23330,714.9129,981.29228,400.4428,602.62527,957.00727,416.33826,218.60126,103.04823,420.19820,335.36518,320.20517,297.4716,035.1615,314.7614,430.181
Gross Profit 4,380.7553,182.6883,614.6983,203.2273,439.8293,265.1683,498.633,271.0683,202.7382,967.0752,538.1772,254.4542,279.1491,938.8531,870.0071,638.716
Gross Profit Ratio 0.110.0940.1080.1010.1070.1050.1130.1110.1090.1120.1110.110.1160.1080.1090.102
Reseach & Development Expenses 0000000000000000
General & Administrative Expenses 27524626823724827028328026027828100000
Selling & Marketing Expenses 2,268.7381,466.7161,497.1021,478.4771,511.0181,506.0351,406.2471,441.1081,389.3981,30289500000
SG&A 2,543.7381,712.7161,765.1021,715.4771,759.0181,776.0351,689.2471,721.1081,649.3981,5801,17600000
Other Expenses -277.793303.931109.642182.71655.24849.82415.40510.18124.00563.55210.85910.69616.00911.305-4.968-9.619
Operating Expenses 2,821.5312,247.5172,338.862,175.172,234.9992,221.8982,092.6592,070.8641,776.3611,698.5671,280.9331,154.6991,064.939949.516894.447888.858
Operating Income 1,559.224935.1691,275.8381,028.0561,204.8291,043.2691,405.971,200.2031,426.3761,268.5071,257.2431,099.7541,214.21989.335975.559749.857
Operating Income Ratio 0.0390.0280.0380.0330.0380.0330.0450.0410.0490.0480.0550.0530.0620.0550.0570.047
Total Other Income Expenses Net 103.442378.594200.623413.59367.913124.733533.786365.842131.873102.361-34.696307.701-12.853-23.7-108.696-100.71
Income Before Tax 1,662.6661,313.7631,476.4611,441.6491,272.7421,168.0021,939.7561,566.0451,558.2491,370.8681,222.5471,407.4551,201.357965.635866.863649.147
Income Before Tax Ratio 0.0420.0390.0440.0460.040.0370.0630.0530.0530.0520.0530.0680.0610.0540.050.04
Income Tax Expense 581.07540.477607.081606.656470.749456.353701.493610.001647.665573.4536.802616.516577.298452.917409.532319.922
Net Income 1,039.786759.598852.328834.993801.993711.6491,238.263956.043910.584797.468685.745790.939624.059512.718457.331329.224
Net Income Ratio 0.0260.0220.0250.0260.0250.0230.040.0320.0310.030.030.0380.0320.0290.0270.02
EPS 276.71202.2226.92221.31210.37185.95323.12249.48237.62208.1178.94206.39163.04133.86189.92167.06
EPS Diluted 276.71202.2226.92221.31210.37185.95323.12249.48237.62208.1178.94206.39163.04133.86189.92167.06
EBITDA 2,343.12,119.8432,286.6162,075.8372,110.2821,964.6852,240.6091,996.1692,287.42,007.7381,754.491,539.6291,621.3191,322.6381,272.6321,006.791
EBITDA Ratio 0.0590.0630.0680.0660.0660.0630.0720.0680.0780.0760.0770.0750.0830.0740.0740.063